1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Zoetis Inc (ZTS)
  7. Quote


Zoetis Stock Price

0.01 (0.0%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Zoetis Inc ZTS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.0% 202.23 15:12:42
Open Price Low Price High Price Close Price Prev Close
202.42 200.76 202.5206 202.22
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,486 494,246 $ 201.87 $ 99,774,320 - 141.41 - 210.10
Last Trade Time Type Quantity Stock Price Currency
15:12:43 4 $ 202.225 USD


Draw Mode:

Zoetis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 95.85B 473.94M 473.38M $ 6.68B $ 1.69B 3.42 50.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.80 0.49% 10/28/21 -25.63k 0.10%

more financials information »

Zoetis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZTS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week197.56202.80195.77199.021,212,6984.672.36%
1 Month196.67205.98190.93197.771,529,1435.562.83%
3 Months202.61210.10190.93201.441,413,755-0.38-0.19%
6 Months167.50210.10165.22189.871,604,99634.7320.73%
1 Year164.62210.10141.41173.651,758,82737.6122.85%
3 Years92.48210.1078.90134.801,971,950109.75118.67%
5 Years50.57210.1046.86104.842,128,151151.66299.9%

Zoetis Description

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.